JPRN-jRCT1052210122尚未招募未知
A Multicenter, Randomized, Parallel-Group Study of the Efficacy and Safety of a Low Ablation Index Group versus a High Ablation Index Group during Extensive Encircling Pulmonary Vein Isolation for Atrial Fibrillation
Shizuta Satoshi0 个研究点目标入组 200 人开始时间: 2021年11月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 85age old（—）
- 性别
- All
入选标准
- •All of the following criteria should be met.
- •(1) Patients undergoing initial ablation for atrial fibrillation (regardless of duration).
- •(2) Female/male patients who are aged 20 years or older and 85 years or younger at the time of consent/enrollment.
排除标准
- •Patients should be excluded if any of the following conditions apply
- •(1) Patients with contraindications to anticoagulation.
- •(2) Patients with thrombus in the left atrium.
- •(3) Other patients who are judged by the principal investigator or sub-investigator to be inappropriate for this study.
研究者
相似试验
尚未招募
不适用
Optimal Ablation Index for Atrial Fibrillation during Extensive Encircling Pulmonary Vein Isolation StudyAtrial fibrillationJPRN-UMIN000044871Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University200
已完成
2 期
A multicenter, randomized, parallel-group study to assess the safety and efficacy of adhesion prevention device, BAX 602, in preventing adhesion of heart and great vessels to surroundings after placement of extracorporeal ventricular assist device (VAD)Patients undergoing open surgery for VAD placement to treat acute circulatory failure, who fulfill all the inclusion and exclusion criteria at the time of enrollment will be enrolled as eligible patients.JPRN-UMIN000038998ational Cerebral and Cardiovascular Center30
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidseiomyomaMedDRA version: 21.1Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10016628Term: FibroidsSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10022794Term: Intramural leiomyoma of uterusSystem Organ Class: 100000004864EUCTR2016-002855-48-SKBayer AG766
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidseiomyomaMedDRA version: 20.0Level: LLTClassification code 10046784Term: Uterine fibroidsSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10016628Term: FibroidsSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10022794Term: Intramural leiomyoma of uterusSystem Organ Class: 100000004864EUCTR2016-002855-48-CZBayer AG766
进行中（未招募）
1 期
Assess Safety and Efficacy of Vilaprisan in Subjects with Uterine FibroidsEUCTR2016-002855-48-NOBayer AG1,200